KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quest Diagnostics (DGX) Capital Expenditures: 2009-2025

Historic Capital Expenditures for Quest Diagnostics (DGX) over the last 17 years, with Sep 2025 value amounting to $144.0 million.

  • Quest Diagnostics' Capital Expenditures rose 35.85% to $144.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $492.0 million, marking a year-over-year increase of 31.55%. This contributed to the annual value of $425.0 million for FY2024, which is 4.17% up from last year.
  • According to the latest figures from Q3 2025, Quest Diagnostics' Capital Expenditures is $144.0 million, which was up 33.33% from $108.0 million recorded in Q2 2025.
  • In the past 5 years, Quest Diagnostics' Capital Expenditures ranged from a high of $147.0 million in Q4 2022 and a low of $63.0 million during Q1 2022.
  • Over the past 3 years, Quest Diagnostics' median Capital Expenditures value was $106.0 million (recorded in 2024), while the average stood at $109.3 million.
  • Within the past 5 years, the most significant YoY rise in Quest Diagnostics' Capital Expenditures was 101.59% (2023), while the steepest drop was 51.02% (2023).
  • Quest Diagnostics' Capital Expenditures (Quarterly) stood at $144.0 million in 2021, then grew by 2.08% to $147.0 million in 2022, then tumbled by 51.02% to $72.0 million in 2023, then surged by 70.83% to $123.0 million in 2024, then soared by 35.85% to $144.0 million in 2025.
  • Its Capital Expenditures stands at $144.0 million for Q3 2025, versus $108.0 million for Q2 2025 and $117.0 million for Q1 2025.